Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probiotics: an emerging therapy.

G C O'Sullivan1, P Kelly, S O'Halloran

  • 1Cork Cancer Research Centre, Mercy University Hospital, National University of Ireland, Cork, Ireland. geraldc@iol.ie

Current Pharmaceutical Design
|January 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In situ formation of micro/nano phase composite for 3D printing clinically relevant bioresorbable stents.

Materials today. Chemistry·2025
Same author

Features and frequency of use of electronic health records in primary care across 20 countries: a cross-sectional study.

Public health·2024
Same author

Extending Pharmacy Services to the Point of Discharge.

Irish medical journal·2023
Same author

Recurrent Lung Injury Resulting From Unusual Cases of Aero-Digestive Disease.

Dysphagia·2023
Same author

Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.

Journal of medical case reports·2022
Same author

BSHI/BTS guidance on crossmatching before deceased donor kidney transplantation.

International journal of immunogenetics·2021
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Probiotic therapy, using beneficial bacteria, shows promise for treating gastrointestinal disorders like inflammatory bowel disease and diarrhea. Further clinical trials are needed to confirm the effectiveness of these live microorganisms.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Immunology

Background:

  • The gastrointestinal tract's microflora is crucial for mucosal protection, immune system development, and waste metabolism.
  • Disruptions to this microbial ecosystem can arise from various factors, including pathogen invasion and modern medical interventions.
  • Probiotic therapy involves administering live, non-pathogenic bacteria to restore or enhance gut health.

Purpose of the Study:

  • To explore the clinical utility of probiotic therapy for treating gastrointestinal disorders.
  • To summarize the mechanisms by which probiotics exert therapeutic effects.
  • To highlight the need for further research into probiotic efficacy.

Main Methods:

  • Review of recent data supporting probiotic use.

Related Experiment Videos

  • Analysis of mechanisms of probiotic action.
  • Identification of gastrointestinal conditions potentially benefiting from probiotics.

    • Main Results:

    • Probiotics are supported by recent data for preventing and treating flora-related gastrointestinal issues.
    • Conditions include inflammatory bowel disease, infectious and antibiotic-associated diarrheas, and pouchitis.
    • Probiotic mechanisms include pathogen competition, antimicrobial production, and immune modulation.

    Conclusions:

    • Probiotic therapy is a promising approach for managing various gastrointestinal disorders.
    • Proven probiotic organisms demonstrate therapeutic activity through multiple mechanisms.
    • Controlled clinical trials are essential to validate the benefits of probiotics.